- Home
- Publications
- Publication Search
- Publication Details
Title
What's in a name? Renaming ‘NAFLD’ to ‘MAFLD’
Authors
Keywords
-
Journal
LIVER INTERNATIONAL
Volume 40, Issue 6, Pages 1254-1261
Publisher
Wiley
Online
2020-04-17
DOI
10.1111/liv.14478
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease
- (2020) Stefano Romeo et al. Cell Metabolism
- MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. GASTROENTEROLOGY
- Update on NAFLD genetics: from new variants to the clinic
- (2020) Eric Trépo et al. JOURNAL OF HEPATOLOGY
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- Are Nonalcoholic Fatty Liver Disease and Alcoholic Fatty Liver Disease More Than Just Semantics?
- (2019) Mohammed Eslam et al. GASTROENTEROLOGY
- Genetic Insights for Drug Development in NAFLD
- (2019) Mohammed Eslam et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Egyptian liver library: An indexed database for liver disease evidence in Egypt
- (2019) Mohamed Alboraie et al. Arab Journal of Gastroenterology
- A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe
- (2019) Jeffrey V. Lazarus et al. JOURNAL OF HEPATOLOGY
- Alcohol Use is Associated with Hepatic Steatosis Among Persons with Presumed Non-alcoholic Fatty Liver Disease
- (2019) Michelle T. Long et al. Clinical Gastroenterology and Hepatology
- Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology
- (2019) Mohammed Eslam et al. Nature Reviews Gastroenterology & Hepatology
- Fatty Liver Disease Caused by High-Alcohol-Producing Klebsiella pneumoniae
- (2019) Jing Yuan et al. Cell Metabolism
- Obeticholic acid: towards first approval for NASH
- (2019) Mohammed Eslam et al. LANCET
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
- (2019) Zobair M Younossi et al. LANCET
- Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission
- (2019) Shiv K Sarin et al. Lancet Gastroenterology & Hepatology
- Interaction between alcohol consumption and metabolic syndrome in predicting severe liver disease in the general population
- (2018) Fredrik Åberg et al. HEPATOLOGY
- Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science
- (2018) Mohammad Shadab Siddiqui et al. HEPATOLOGY
- Non-heavy drinking and worsening of non-invasive fibrosis markers in nonalcoholic fatty liver disease: A cohort study
- (2018) Yoosoo Chang et al. HEPATOLOGY
- Underappreciation of non-alcoholic fatty liver disease by primary care clinicians: limited awareness of surrogate markers of fibrosis
- (2018) Preya J. Patel et al. INTERNAL MEDICINE JOURNAL
- «The times they are a’changin’» – Positioning the European Association for the Study of the Liver in the changing landscape of hepatology
- (2018) Tom H. Karlsen et al. JOURNAL OF HEPATOLOGY
- Genetics and epigenetics of NAFLD and NASH: Clinical impact
- (2018) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease
- (2018) Myriam Alexander et al. BMC Medicine
- The Lancet–EASL Commission on liver diseases in Europe: overcoming unmet needs, stigma, and inequities
- (2018) Michael P Manns et al. LANCET
- Hepatic fat as clinical outcome and therapeutic target for nonalcoholic fatty liver disease
- (2018) Serena Pelusi et al. LIVER INTERNATIONAL
- Understanding Patient Preferences and Unmet Needs in Non-alcoholic Steatohepatitis (NASH): Insights from a Qualitative Online Bulletin Board Study
- (2018) Nigel S. Cook et al. ADVANCES IN THERAPY
- Renaming schizophrenia
- (2018) Toshimasa Maruta et al. Epidemiology and Psychiatric Sciences
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment
- (2017) Vincent Wai-Sun Wong et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver
- (2017) P. Dongiovanni et al. JOURNAL OF INTERNAL MEDICINE
- You're not speaking my language: reframing NCDs for politicians and policy makers
- (2017) Luke N Allen LANCET
- Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
- (2017) Zobair Younossi et al. Nature Reviews Gastroenterology & Hepatology
- Associations between renaming schizophrenia and stigma-related outcomes: A systematic review
- (2017) Sosei Yamaguchi et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Renaming non-communicable diseases
- (2017) Ellen Elizabeth Kozelka et al. Lancet Global Health
- Renaming non-communicable diseases
- (2017) Paul Lincoln Lancet Global Health
- Renaming non-communicable diseases
- (2017) Guanyang Zou et al. Lancet Global Health
- Beyond divisive dichotomies in disease classification
- (2017) Felicia Marie Knaul et al. Lancet Global Health
- What's in a name? A call to reframe non-communicable diseases
- (2017) Luke N Allen et al. Lancet Global Health
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- NAFLD: A multisystem disease
- (2015) Christopher D. Byrne et al. JOURNAL OF HEPATOLOGY
- Practice patterns in NAFLD and NASH: real life differs from published guidelines
- (2015) Mary E. Rinella et al. Therapeutic Advances in Gastroenterology
- Non-alcoholic fatty liver disease, obesity and the metabolic syndrome
- (2014) Peter Dietrich et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Consequences of Perceived Stigma Among Patients with Cirrhosis
- (2013) Valerie Vaughn-Sandler et al. DIGESTIVE DISEASES AND SCIENCES
- Effect of lifetime alcohol consumption on the histological severity of non-alcoholic fatty liver disease
- (2013) Hellan K. Kwon et al. LIVER INTERNATIONAL
- Stigma and treatment delay in first-episode psychosis: a grounded theory study
- (2010) Lauren Franz et al. Early Intervention in Psychiatry
- A position statement on NAFLD/NASH based on the EASL 2009 special conference
- (2010) Vlad Ratziu et al. JOURNAL OF HEPATOLOGY
- Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease
- (2008) Mattias Ekstedt et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started